Avecho Biotechnology Limited (AVEFF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 473.55 Thousand | 1.2 Million | 793.6 Thousand | 384.62 Thousand | 4.23 Million | 1.25 Million |
| Cost of Revenue | 517.34 Thousand | 336.14 Thousand | 285.66 Thousand | 143.71 Thousand | 214.57 Thousand | 553.32 Thousand |
| Gross Profit | -43.79 Thousand | 870.02 Thousand | 507.93 Thousand | 240.91 Thousand | 4.02 Million | 698.99 Thousand |
| Operating Expenses | 4.36 Million | 3.93 Million | 5.05 Million | 3.64 Million | 3.52 Million | 6.02 Million |
| Selling, General and Administrative Expenses | 3.07 Million | 2.26 Million | 2.59 Million | 1.78 Million | 1.29 Million | 2.75 Million |
| Research and Development Expenses | 2.11 Million | 1.59 Million | 1.54 Million | 187.6 Thousand | 166.04 Thousand | 353.54 Thousand |
| Other Expenses | - | 646.56 Thousand | 1.14 Million | 777.68 Thousand | 458.92 Thousand | 1.44 Million |
| Cost and Expenses | 5.06 Million | 4.26 Million | 5.34 Million | 3.79 Million | 3.73 Million | 6.57 Million |
| Operating Income | -4.58 Million | -2.33 Million | -3.4 Million | -2.62 Million | 969.6 Thousand | -5.16 Million |
| Interest Expense | 15.35 Thousand | 6349.00 | 9975.00 | 5925.00 | 11.03 Thousand | - |
| Income Tax Expense | - | 652.91 Thousand | 1.15 Million | 783.6 Thousand | 469.96 Thousand | 114.72 Thousand |
| Earnings before Tax | -3.43 Million | -2.34 Million | -3.41 Million | -2.63 Million | 849.95 Thousand | -3.99 Million |
| Net Income | -3.43 Million | -2.34 Million | -3.41 Million | -2.63 Million | 849.95 Thousand | -3.99 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Weighted Average Shares Outstanding | 2.26 Billion | 1.83 Billion | 1.8 Billion | 1.59 Billion | 1.57 Billion | 1.57 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.26 Billion | 1.83 Billion | 1.8 Billion | 1.59 Billion | 1.57 Billion | 1.57 Billion |
| Gross Margin | -0.09 | 0.72 | 0.64 | 0.63 | 0.95 | 0.56 |
| EBIT Margin | -6.85 | -1.87 | -3.75 | -5.44 | 0.39 | -3.55 |
| Profit Margin | -7.26 | -1.94 | -4.30 | -6.85 | 0.20 | -3.19 |
| EBITDA | -3.24 Million | -2.1 Million | -2.97 Million | -2.09 Million | 1.54 Million | -4.59 Million |
| Earnings Before Tax Margin | -9.69 | -1.94 | -4.29 | -6.83 | 0.23 | -4.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 156.09 Thousand | 156.09 Thousand | 27.11 Thousand | 473.55 Thousand | 13.55 Thousand | 446.43 Thousand |
| Cost of Revenue | 52.49 Thousand | 52.49 Thousand | 463.39 Thousand | 696.04 Thousand | 194.51 Thousand | 232.64 Thousand |
| Gross Profit | 103.59 Thousand | 103.59 Thousand | -436.28 Thousand | -222.49 Thousand | -180.96 Thousand | 213.79 Thousand |
| Operating Expenses | 1.55 Million | 1.55 Million | 1.63 Million | 4.36 Million | 469.66 Thousand | 2.73 Million |
| Selling, General and Administrative Expenses | 578.44 Thousand | 578.44 Thousand | 623.87 Thousand | - | 349.11 Thousand | 1.62 Million |
| Research and Development Expenses | 972.57 Thousand | 972.57 Thousand | 1 Million | - | 503.11 Thousand | 1.11 Million |
| Other Expenses | - | - | - | 1.13 Million | - | - |
| Cost and Expenses | 1.6 Million | 1.6 Million | 2.09 Million | 5.06 Million | 664.18 Thousand | 2.96 Million |
| Operating Income | -1.44 Million | -1.44 Million | -2.06 Million | -4.58 Million | -650.63 Thousand | -2.52 Million |
| Interest Expense | 5590.00 | - | 7787.00 | 15.35 Thousand | - | 7569.00 |
| Income Tax Expense | -523.73 Thousand | 362.59 Thousand | -695.58 Thousand | -1.07 Million | - | -379.98 Thousand |
| Earnings before Tax | -1.08 Million | -1.08 Million | -2 Million | -4.51 Million | -654.52 Thousand | -2.5 Million |
| Net Income | -1.08 Million | -1.08 Million | -1.3 Million | -3.43 Million | -654.52 Thousand | -2.12 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.1 Billion | 3.1 Billion | 3.16 Billion | 2.26 Billion | 2.6 Billion | 1.93 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.16 Billion | 3.16 Billion | 3.16 Billion | 2.26 Billion | 2.6 Billion | 1.93 Billion |
| Gross Margin | 0.66 | 0.66 | -16.09 | -0.47 | -13.35 | 0.48 |
| EBIT Margin | -6.71 | -6.71 | -73.47 | - | -45.25 | -5.42 |
| Profit Margin | -6.97 | -6.97 | -48.28 | -7.26 | -48.28 | -4.77 |
| EBITDA | -1.04 Million | -1.04 Million | -1.99 Million | - | -613.45 Thousand | -2.41 Million |
| Earnings Before Tax Margin | -9.27 | -9.27 | -76.22 | -9.69 | -48.00 | -5.65 |
UV-R
1979
ASAZF
4533
2322
ENTO